337 related articles for article (PubMed ID: 7153706)
21. The complement fragment C3d facilitates phagocytosis by monocytes.
Gaither TA; Vargas I; Inada S; Frank MM
Immunology; 1987 Nov; 62(3):405-11. PubMed ID: 3499379
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the binding of C3S and C3F to complement receptors types 1, 2, and 3.
Bartók I; Walport MJ
J Immunol; 1995 May; 154(10):5367-75. PubMed ID: 7730637
[TBL] [Abstract][Full Text] [Related]
23. Characterization of the C3 receptor induced by herpes simplex virus type 1 infection of human epidermal, endothelial, and A431 cells.
Kubota Y; Gaither TA; Cason J; O'Shea JJ; Lawley TJ
J Immunol; 1987 Feb; 138(4):1137-42. PubMed ID: 3027170
[TBL] [Abstract][Full Text] [Related]
24. Neutrophils express a receptor for iC3b, C3dg, and C3d that is distinct from CR1, CR2, and CR3.
Vik DP; Fearon DT
J Immunol; 1985 Apr; 134(4):2571-9. PubMed ID: 3156185
[TBL] [Abstract][Full Text] [Related]
25. Complement receptors on Raji cells. The presence of a new type of C3 receptor.
Okuda T; Tachibana T
Immunology; 1980 Sep; 41(1):159-66. PubMed ID: 7429548
[TBL] [Abstract][Full Text] [Related]
26. Expression of specific binding sites on Candida with functional and antigenic characteristics of human complement receptors.
Edwards JE; Gaither TA; O'Shea JJ; Rotrosen D; Lawley TJ; Wright SA; Frank MM; Green I
J Immunol; 1986 Dec; 137(11):3577-83. PubMed ID: 2946764
[TBL] [Abstract][Full Text] [Related]
27. CD44 Antibody Inhibition of Macrophage Phagocytosis Targets Fcγ Receptor- and Complement Receptor 3-Dependent Mechanisms.
Amash A; Wang L; Wang Y; Bhakta V; Fairn GD; Hou M; Peng J; Sheffield WP; Lazarus AH
J Immunol; 2016 Apr; 196(8):3331-40. PubMed ID: 26944929
[TBL] [Abstract][Full Text] [Related]
28. Analysis of C3-receptor activity on human B-lymphocytes and isolation of the complement receptor type 2 (CR2).
Micklem KJ; Sim RB; Sim E
Biochem J; 1984 Nov; 224(1):75-86. PubMed ID: 6239618
[TBL] [Abstract][Full Text] [Related]
29. Evidence for distinct intracellular pools of receptors for C3b and C3bi in human neutrophils.
O'Shea JJ; Brown EJ; Seligmann BE; Metcalf JA; Frank MM; Gallin JI
J Immunol; 1985 Apr; 134(4):2580-7. PubMed ID: 3156186
[TBL] [Abstract][Full Text] [Related]
30. Modulation of complement receptors of a human monocyte cell line, U-937, during incubation with phorbol myristate acetate: expression of an iC3b-specific receptor (CR3).
Gilbert D; Peulve P; Daveau M; Ripoche J; Fontaine M
Eur J Immunol; 1985 Oct; 15(10):986-91. PubMed ID: 2932340
[TBL] [Abstract][Full Text] [Related]
31. Defective complement receptors (CR1 and CR3) on erythrocytes and leukocytes of factor I (C3b-inactivator) deficient patients.
Porteu F; Fischer A; Descamps-Latscha B; Halbwachs-Mecarelli L
Clin Exp Immunol; 1986 Nov; 66(2):463-71. PubMed ID: 2949901
[TBL] [Abstract][Full Text] [Related]
32. Complement receptor type three-dependent degradation of opsonized erythrocytes by mouse macrophages.
Rothlein R; Springer TA
J Immunol; 1985 Oct; 135(4):2668-72. PubMed ID: 3897377
[TBL] [Abstract][Full Text] [Related]
33. Monoclonal antibody to the murine type 3 complement receptor inhibits adhesion of myelomonocytic cells in vitro and inflammatory cell recruitment in vivo.
Rosen H; Gordon S
J Exp Med; 1987 Dec; 166(6):1685-701. PubMed ID: 2445894
[TBL] [Abstract][Full Text] [Related]
34. Roles of CR3 and mannose receptors in the attachment and ingestion of Leishmania donovani by human mononuclear phagocytes.
Wilson ME; Pearson RD
Infect Immun; 1988 Feb; 56(2):363-9. PubMed ID: 2962944
[TBL] [Abstract][Full Text] [Related]
35. C3 modified at the thiolester site: acquisition of reactivity with cellular C3b receptors.
Schreiber RD; Pangburn MK; Müller-Eberhard HJ
Biosci Rep; 1981 Nov; 1(11):873-80. PubMed ID: 6458338
[TBL] [Abstract][Full Text] [Related]
36. C3bi/CR3 is a main ligand-receptor interaction in attachment and phagocytosis of C3-coated particles by mouse peritoneal macrophages.
Kimura M; Griffin FM
Scand J Immunol; 1992 Aug; 36(2):183-91. PubMed ID: 1502493
[TBL] [Abstract][Full Text] [Related]
37. Xenoantiserum to human C3 receptors: its preparation and effect on the C3b and C3d receptors of tonsil cells and the C3b receptors of erythrocytes and neutrophils.
Gerdes J; Klatt U; Stein H
Immunology; 1980 Jan; 39(1):75-84. PubMed ID: 6991397
[TBL] [Abstract][Full Text] [Related]
38. Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes.
Weis JJ; Tedder TF; Fearon DT
Proc Natl Acad Sci U S A; 1984 Feb; 81(3):881-5. PubMed ID: 6230668
[TBL] [Abstract][Full Text] [Related]
39. Monoclonal antibodies to mouse complement receptor type 1 (CR1). Their use in a distribution study showing that mouse erythrocytes and platelets are CR1-negative.
Kinoshita T; Takeda J; Hong K; Kozono H; Sakai H; Inoue K
J Immunol; 1988 May; 140(9):3066-72. PubMed ID: 2966205
[TBL] [Abstract][Full Text] [Related]
40. A monoclonal antibody (3A33) that reacts with a mouse-specific epitope of Mac-1 antigen.
Martin A; Le Corre R; Pellen P; Bourel D; Merdrignac G; Genetet B; Toujas L
Tissue Antigens; 1986 Jul; 28(1):15-23. PubMed ID: 2428126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
